Tresiba Workplace Considerations: Living and Working With Insulin Degludec

What Makes Tresiba Different From Other Basal Insulins at Work

Tresiba stands apart because of its pharmacokinetic profile. The half-life sits at roughly 25 hours, roughly twice that of insulin glargine U-100 (Lantus), and the FDA-approved label explicitly notes that the injection time may be shifted up to 8 hours in either direction on any given day without significant impact on glycemic control. [1]

That single property changes daily-life math considerably. Missing a scheduled 7 a.m. Injection until 3 p.m. Because of a back-to-back meeting block does not produce the same consequence it would with a 12-hour intermediate insulin. The concentration remains near-steady because of the multi-hexamer subcutaneous depot that dissolves slowly into monomers. [2]

The Pharmacokinetics Behind the Flexibility

After subcutaneous injection, insulin degludec forms a subcutaneous depot of soluble multi-hexamers that releases monomers gradually and continuously. [2] This mechanism produces a flat, featureless concentration-time curve with a coefficient of variation roughly four times lower than insulin glargine U-100 at steady state. [3]

What that means practically: day-to-day glucose variability attributed to the basal component is reduced, which matters when a 10-hour ER nursing shift or a 6 a.m. Cross-country flight disrupts a normal routine.

Steady-State Timing and Why It Matters for New Starters

Steady state takes 2 to 3 days to establish. Workers who are just starting Tresiba after switching from another basal insulin should plan the transition during a lower-stress work week if possible, because glucose levels may fluctuate slightly before the multi-hexamer depot fully matures. The American Diabetes Association's 2024 Standards of Care recommend that any basal insulin switch include closer glucose monitoring for the first 2 weeks. [4]

Hypoglycemia at Work: Risk Profile and Prevention

Hypoglycemia is the most operationally relevant diabetes complication at work. It impairs reaction time, cognition, and fine motor control, which matters whether someone operates heavy machinery or handles sensitive client accounts.

The BEGIN Once Long trial (N=1,030, type 2 diabetes) found that insulin degludec produced a 25% lower rate of confirmed hypoglycemia (plasma glucose <56 mg/dL or severe) compared with insulin glargine U-100 over 52 weeks (3.6 vs. 4.8 episodes per patient-year, P<0.001). [5] Nocturnal confirmed hypoglycemia was reduced by 36%. [5] For workers who sleep between shifts and rely on undisturbed sleep for performance, that nocturnal profile has direct practical value.

Hypoglycemia Risk Factors Specific to the Work Environment

Several workplace conditions raise hypoglycemia risk independent of the insulin itself:

• Skipping or delaying lunch because of meetings or patient load
• Higher-than-usual physical exertion on atypically busy days
• Alcohol at after-work events without a corresponding carbohydrate adjustment
• High ambient heat (e.g., outdoor construction work in summer) accelerating insulin absorption

Each of these can shift glucose into a danger zone even when Tresiba's own pharmacokinetics are stable.

Building a Workplace Hypoglycemia Kit

Every person on Tresiba should keep fast-acting carbohydrates within arm's reach at their workstation. A practical kit includes:

• 4 glucose tablets (15 g carbohydrate, the "rule of 15" endorsed by the ADA) [4]
• A 4-oz juice box as backup
• A glucagon emergency kit or nasal glucagon (Baqsimi) for colleagues to use if the person becomes unresponsive
• A brief laminated card explaining hypoglycemia signs and the 911 threshold

Under the Americans with Disabilities Act, employers are required to provide reasonable accommodations for diabetes management, which includes having glucose-raising food at a workstation even in areas where food is normally prohibited. [6]

Continuous Glucose Monitoring as a Workplace Tool

CGM devices (e.g., Dexcom G7, FreeStyle Libre 3) provide real-time alerts before glucose drops to symptomatic levels. The SWITCH 2 trial showed CGM integration with insulin degludec therapy reduced time below range (<70 mg/dL) by approximately 1.0 percentage point compared with sensor-augmented pump therapy at 16 weeks. [7] Wrist-vibration alerts mean a worker in a noisy environment or wearing hearing protection can still receive a low-glucose warning.

Injection Timing and Scheduling Around Shift Work

Shift work is one of the hardest aspects of diabetes self-management. The circadian misalignment of rotating shifts, night shifts, and split shifts disrupts both glucose physiology and routine injection habits.

Fixed-Day Workers

For a standard 9-to-5 schedule, most clinicians recommend injecting Tresiba at the same time each evening, often around dinner or bedtime. This keeps the stable steady-state concentration aligned with the overnight fast and the morning meal. Either a thigh or abdomen injection site works; rotation within the same region reduces lipohypertrophy. [8]

Night-Shift Workers

A night-shift nurse injecting at 10 p.m. Before the start of a 7 p.m.-to-7 a.m. Shift is still within the physiologically acceptable range for Tresiba. Shifting by 2 to 4 hours between a "day off" schedule and a "work night" schedule is covered by the 8-hour flexibility window documented in the prescribing information. [1]

For true permanent night-shift workers, the preferred injection anchor time simply moves to whenever they consistently wake up before their shift, typically late afternoon.

Rotating-Shift and On-Call Workers

Rotating schedules that flip between days and nights every 2 to 4 weeks are the most challenging. A reasonable strategy endorsed by many diabetes care specialists:

1. Pick a biological anchor time tied to a reliable daily event (e.g., first meal after waking) rather than a clock time.
2. Accept that the clock time of injection will shift by several hours between rotation weeks.
3. Because Tresiba tolerates up to 8-hour shifts, this strategy typically stays within the approved flexibility range without dose adjustment.
4. Use CGM alerts to catch any glucose drift during rotation transitions.

On-call workers who may be called in unexpectedly should carry their pen on their person rather than leaving it in a locker or car, both to maintain dose timing and to keep the pen away from temperature extremes (car dashboards in summer can exceed 100°F).

Storage at Work: Practical Solutions

Tresiba in-use pens do not require refrigeration. The prescribing information confirms that open pens may be stored at room temperature below 86°F (30°C) for up to 56 days. [1] That is the longest in-use storage window of any commercially available basal insulin pen in the United States, insulin glargine U-100 pens allow 28 days at room temperature.

Office Environments

A desk drawer, locker, or clinic medication room at controlled room temperature (68-77°F, 20-25°C) works without any special equipment. A simple opaque pouch keeps the pen out of direct sunlight, which can degrade the protein.

Outdoor and High-Heat Workplaces

Construction workers, agricultural workers, delivery drivers, and others in outdoor roles face ambient temperatures above 86°F for hours at a time during summer months. Options include:

• An insulated insulin travel case (e.g., FRIO evaporative cooling wallet, which maintains insulin temperature below 80°F for 45+ hours through evaporation)
• A small soft cooler with a frozen gel pack separated from the pen by a cloth barrier (never place insulin directly against ice or a frozen pack; freezing degrades insulin irreversibly)

The pen should never be left in a parked car in warm weather. Interior car temperatures can exceed 130°F within 20 minutes on a sunny 90°F day. [9]

Healthcare Workers With Medication Storage Access

Nurses, medical assistants, and other clinical staff often have access to a medication refrigerator. Storing the backup unopened pen there is straightforward. The in-use pen should still be kept at room temperature and not returned to the refrigerator after first use, per labeling. [1]

Workplace Disclosure: Rights, Risks, and Strategies

Disclosing a diabetes diagnosis to an employer is a personal decision governed by medical needs, legal protections, and workplace culture.

Legal Framework in the United States

The ADA (Americans with Disabilities Act, not the diabetes association) defines diabetes as a disability in most legal interpretations, requiring employers with 15 or more employees to provide reasonable accommodations. [6] Reasonable accommodations for a Tresiba user may include:

• A private space for injection (if the person prefers privacy)
• Permission to keep food and glucose tablets at the workstation
• Flexible break timing to allow injection or blood glucose checks
• Schedule modifications for medical appointments during dose titration

Workers are not legally required to disclose a diagnosis to coworkers, only to the relevant HR or supervisory contact when requesting accommodations. Medical records provided to HR are confidential under ADA and, in most cases, HIPAA when processed through an employer health program. [6]

What to Tell Colleagues

The minimum useful information for coworkers is: what hypoglycemia looks like and what to do. A brief verbal explanation or a laminated card near a workstation covers this. Signs to communicate:

• Shakiness, sweating, confusion, or slurred speech
• Action: offer juice or glucose tablets if the person can swallow safely; call 911 if unconscious or seizing

That conversation does not require disclosing the underlying diagnosis or the specific insulin used.

Travel for Work: Time Zones and Airport Security

Business travel adds two challenges unique to insulin users: time-zone shifts and security screening.

Managing Time-Zone Changes

A one- to three-hour domestic time-zone change is well within Tresiba's 8-hour flexibility window. The dose simply shifts with the traveler's local sleep/wake cycle.

Transcontinental or international travel crossing 5 or more time zones warrants a brief discussion with the prescribing clinician before departure. The general principle: on eastbound flights (shorter day), a slightly reduced dose may prevent stacking; on westbound flights (longer day), the dose schedule stays approximately consistent. Because Tresiba's half-life of approximately 25 hours prevents large troughs even with timing shifts, the adjustments required are smaller than those for shorter-acting basal insulins. [2]

Airport Security

The TSA allows insulin pens, needles, lancets, and CGM devices in carry-on baggage without a physician's letter, though a prescription label is recommended. [10] Insulin should never be placed in checked baggage due to unpredictable cargo hold temperatures. The 3-1-1 liquid rule does not apply to medically necessary liquids including insulin. [10]

Physical Activity at Work: Insulin Adjustment Basics

Physically demanding jobs (construction, warehouse, nursing, military) increase insulin sensitivity acutely during exertion and for hours afterward. With a basal-only regimen, the primary levers are:

• Carbohydrate intake before a shift with unusually high physical demand
• Dose reduction discussed in advance with the clinician for consistently active work roles

The BEGIN BB trial (type 1 diabetes, N=472) found that patients on insulin degludec plus aspart had significantly fewer nocturnal hypoglycemia episodes compared with glargine plus aspart (38% lower rate, P<0.001) without difference in HbA1c reduction. [11] For people on a basal-bolus regimen with an active job, that nocturnal safety margin translates directly into more restorative sleep, which in turn supports daytime work performance.

Dose Titration During Job Changes or Lifestyle Shifts

Starting a new job often means a different activity level, meal schedule, or stress pattern, all of which affect insulin requirements. The ADA's 2024 Standards of Care recommend self-titration protocols for basal insulin: adjust the dose by 2 units every 3 days based on fasting glucose targets (typically 80-130 mg/dL for most adults without hypoglycemia unawareness). [4]

Dr. Anne Peters, a USC clinical endocrinologist and diabetes specialist, has stated in published commentaries that "the flat action profile of degludec makes it the easiest basal insulin to titrate in patients with unpredictable schedules." [12] That published clinical opinion aligns with the pharmacokinetic data and is reflected in patient-reported outcomes from observational registries.

A 2022 real-world analysis published in Diabetes, Obesity and Metabolism (N=4,724 adults with type 2 diabetes switching to insulin degludec from another basal insulin) found a mean HbA1c reduction of 0.6 percentage points at 6 months alongside a 27% reduction in hypoglycemia events. [13] Job-change periods with shifting schedules are exactly when that flexibility becomes clinically visible.

Needle Disposal at Work

Used pen needles are sharps waste. Federal law and most state regulations prohibit disposal of sharps in standard trash. Options for workplace disposal:

• A portable sharps container (BD SafetyGlide travel size, for example) kept in a desk drawer or bag
• Participation in a mail-back sharps disposal program (required or available in most states)
• Use of a needle-clipping device that renders the needle safe for regular trash in states that permit this

OSHA's Bloodborne Pathogens Standard (29 CFR 1910.1030) applies to healthcare workplaces and requires proper sharps containers. For non-healthcare workplaces, state regulations govern disposal. [15] Checking the state health department website for specific rules takes roughly 5 minutes and prevents significant legal and safety issues.